Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases

  1. Riva, N.
  2. Brstilo, L.
  3. Sancho-Araiz, A.
  4. Molina, M.
  5. Savransky, A.
  6. Roffé, G.
  7. Sanz, M.
  8. Tenembaum, S.
  9. Katsicas, M.M.
  10. Trocóniz, I.F.
  11. Schaiquevich, P.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2023

Volume: 15

Issue: 11

Type: Article

DOI: 10.3390/PHARMACEUTICS15112534 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus